Prevalence of Helicobacter pylori infection and its association with cardiovascular risk factors in Korean adults

International Journal of Cardiology

Volumn 102, Issue 3, 2005, Pages 411-417

  Ki, Chul Sung ^a   Eun, Jung Rhee ^a   Seung, Ho Ryu ^a   Beck, Sung Ho ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

Atherosclerosis; Helicobacter pylori; Lipid profiles; Risk factors

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BACTERIUM ANTIBODY; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN G ANTIBODY; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTIBODY TITER; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS OF COVARIANCE; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCREENING; SEROPREVALENCE; SEX DIFFERENCE;

ADULT; ANTIBODIES, BACTERIAL; CARDIOVASCULAR DISEASES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; KOREA; LIPIDS; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84928494469     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.05.040     Document Type: Article

References (43)

1. L. Capron, and B. Wyplosz The infection theory in atherosclerosis Arch. Mal. Coeur Vaiss. 91 5 1998 21 26
2. J.B. Muhlestein Bacterial infections and atherosclerosis J. Investig. Med. 46 8 1998 396 402
3. J. Danesh, R. Collins, and R. Peto Chronic infections and coronary heart disease: is there a link? Lancet 350 9075 1997 430 436
4. M.A. Mendall, P.M. Goggin, and N. Molineaux Relation of Helicobacter pylori infection and coronary heart disease Br. Heart J. 71 5 1994 437 439
5. V. Pasceri, G. Cammarota, and G. Patti Association of virulent Helicobacter pylori strains with ischemic heart disease Circulation 97 17 1998 1675 1679
6. D. Rothenbacher, A. Hoffmeister, and G. Bode Helicobacter pylori heat shock protein 60 and risk of coronary heart disease: a case control study with focus on markers of systemic inflammation and lipids Atherosclerosis 156 1 2001 193 199
7. J. Danesh, and R. Peto Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies BMJ 316 7138 1998 1130 1132
8. A. Hoffmeister, D. Rothenbacher, and G. Bode Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or Cytomegalovirus, is associated with an atherogenic, modified lipid profile Arterioscler. Thromb. Vasc. Biol. 21 3 2001 427 432
9. G. Chimienti, F. Russo, and B.L. Lamanuzzi Helicobacter pylori is associated with modified lipid profile: impact on Lipoprotein (a) Clin. Biochem. 36 5 2003 359 365
10. S. Niemela, T. Karttunen, and T. Korhonen Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 75 6 1996 573 575
11. H.M. Malaty, J.G. Kim, S.D. Kim, and D.Y. Graham Prevalence of Helicobacter pylori infection in Korean children. Inverse relation to socioeconomic status despite a uniformly high prevalence in adults Am. J. Epidemiol. 143 1996 257 262
12. D.G. Yong, H.M. Lee, H.S. Kim, J.G. Lee, and Y.C. Lee Clinical usefulness of Helicobacter pylori IgG Ab assay: comparison of six commercial kits Korean J. Clin. Pathol. 18 1998 447 461
13. J. Ness, and W.S. Aronow Prevalence of coronary artery disease, ischemic stroke, peripheral arterial disease, and coronary revascularization in older African-Americans, Asians, Hispanics, whites, men, and women Am. J. Cardiol. 84 8 1999 932 933 A7
14. D.H. Lee Infection and treatment of Helicobacter pylori in Korea Korean J. Gastroenterol. 39 2002 153 160
15. F.C. de Beer, C.R. Hing, and K.M. Fox Measurement of serum C-reactive protein concentration in myocardial ischemia and infarction Br. Heart J. 47 1982 239 243
16. A. Maseri Inflammation, atherosclerosis, and ischemic events-exploring the hidden side of the moon N. Engl. J. Med. 336 1997 1014 1016
17. I.W. Fong Emerging relations between infections disease and coronary artery disease and atherosclerosis CMAJ 163 1 2000 49 56
18. R.A. Young, and T.J. Elliot Stress proteins, infection and immune surveillance Cell 59 1989 5 8
19. P. Saikku, M. Leinonen, and K. Mattila Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction Lancet 2 8618 1988 983 986
20. K.P. High Atherosclerosis and infection due to Chlamydia pneumoniae or Cytomegalovirus: weighing the evidence Clin. Infect. Dis. 28 4 1999 746 749
21. A. Tiran, R.A. Tio, and E. Oostenveld Humoral immune response to human Cytomegalovirus in patients undergoing percutaneous transluminal coronary angioplasty Clin. Diagn. Lab. Immunol. 6 1 1999 45 49
22. B. Rathbone, D. Martin, J. Stephens, J.R. Thompson, and N.J. Samani Helicobacter pylori seropositivity in subjects with acute myocardial infarction Heart 76 4 1996 308 311
23. A.R. Folsom, F.J. Nieto, and P. Sorlie Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis risk in communities (ARIC) study investigators Circulation 98 9 1998 845 850
24. J. Zhu, A.A. Quyyumi, and J.B. Muhlestein Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death Am. J. Cardiol. 89 2 2002 155 158
25. W.C. Tsai, Y.H. Li, and B.S. Sheu Association of elevation of anti-Helicobacter pylori antibody with myocardial ischemic events in coronary artery disease Am. J. Cardiol. 87 8 2001 1005 1007
26. W. Koenig, D. Rothenbacher, and A. Hoffmeister Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease lack of a role of cytotoxin-associated protein a-positive strains and absence of a systemic inflammatory response Circulation 100 1999 2326 2331
27. R.K. Scragg, A. Fraser, and P.A. Metcalf Helicobacter pylori seropositivity and cardiovascular risk factors in a multicultural workforce J. Epidemiol. Community Health 50 5 1996 578 579
28. P. Patel, M.A. Mendall, and D. Carrington Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors BMJ 311 1995 711 714
29. M.J. Blaser Helicobacters are indigenous to the human stomach: duodenal ulceration is due to changes in gastric microecology in modern era Gut 43 1998 721 727
30. F. Blasi, F. Denti, and M. Erba Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms J. Clin. Microbiol. 34 11 1996 2766 2769
31. M. Kowalski Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque J. Physiol. Pharmacol. 52 Suppl. 1 2001 3 31
32. J.Y. Han, J.S. Park, and K.H. Ryu The effect of Helicobacter pylori and Cytomegalovirus infection on re-stenosis after coronary angioplasty Korean Circ. J. 30 1 2000 39 48
33. K.H. Kim, M.H. Chung, and J.H. Shin The role of infection and inflammation in coronary diseases in Korean Korean Circ. J. 30 9 2000 1107 1116
34. P.M. Ridker, C.H. Hennekens, J.E. Buring, R. Kundsin, and J. Shih Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and Cytomegalovirus and the risk for cardiovascular disease in women Ann. Intern. Med. 131 8 1999 573 577
35. D.E. Manolov, W. Koenig, and V. Hombach C-reactive protein and atherosclerosis. Is there a causal link? Histol. Histopathol. 18 4 2003 1189 1193
36. J.S. Yudkin, C.D. Stehouwer, and J.J. Emeis C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol. 19 4 1999 972 978
37. J.L. Anderson, J.F. Carlquist, and J.B. Muhlestein Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction J. Am. Coll. Cardiol. 32 1 1998 35 41
38. L.J. Murray, K.B. Bamford, and D.P. O'Reilly Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class Br. Heart J. 74 5 1995 497 501
39. M.N. Pieters, D. Schouten, and T.J.C. Van Berkel In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport Biochim. Biophys. Acta 1225 1994 125 134
40. A. von Eckardstein, J.R. Nofer, and G. Assmann High density lipoproteins and arteriosclerosis: role of cholesterol efflux and reverse cholesterol transport Arterioscler. Thromb. Vasc. Biol. 21 2001 13 27
41. P.K. Shah, S. Kaul, and J. Nilsson Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming: Part I Circulation 104 2001 2376 2383
42. G.W. Cockerill, K. Rye, and J.R. Gamble High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules Arterioscler. Thromb. Vasc. Biol. 15 1995 1987 1994
43. P. Xia, M.A. Vadas, and K. Rye High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway J. Biol. Chem. 274 1999 33143 33147